Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (SHA:603168)
China flag China · Delayed Price · Currency is CNY
6.12
-0.24 (-3.77%)
May 21, 2026, 3:00 PM CST

SHA:603168 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
72.08112.1882.79355.67525.06138.52
Trading Asset Securities
48.94112.22106.8613.5329.27105.03
Cash & Short-Term Investments
121.03224.4189.65369.2554.33243.55
Cash Growth
-34.59%18.32%-48.63%-33.40%127.60%-46.68%
Accounts Receivable
44.0547.9567.7953.5840.3252.04
Other Receivables
8.143.0912.848.6942.965.16
Receivables
52.1851.0480.6262.2783.2857.2
Inventory
87.5976.7276.6684.3259.160.82
Other Current Assets
22.8816.0319.7436.8731.09192.37
Total Current Assets
283.67368.18366.67552.66727.8553.95
Property, Plant & Equipment
788.89801.42841.87795.34651.26474.12
Long-Term Investments
299.91323.17327.64232.1467.86-
Goodwill
139.67139.67332.09365.43326.68336.16
Other Intangible Assets
142.57143.79150.41154.62160.14165.72
Long-Term Deferred Tax Assets
0.110.460.780.740.820.07
Long-Term Deferred Charges
88.1487.8967.7330.454.741.87
Other Long-Term Assets
28.097.6719.0738.9117.1853.47
Total Assets
1,7711,8722,1062,1701,9561,585
Accounts Payable
95.51120.19137.04123.1180.8525.93
Accrued Expenses
14.4357.3468.8153.0653.969.86
Short-Term Debt
118.52149.61105.2985.98--
Current Portion of Long-Term Debt
-22.824.110.41--
Current Portion of Leases
-5.468.058.545.93-
Current Income Taxes Payable
-0.031.314.52-3.8
Current Unearned Revenue
11.3121.2619.7126.3949.7534.49
Other Current Liabilities
78.7214.5933.1655.6815.3961.2
Total Current Liabilities
318.49391.3377.47367.7205.82195.27
Long-Term Debt
108.32108.57111.5537.07--
Long-Term Leases
12.6214.525.3433.6833.7637.61
Long-Term Unearned Revenue
2.732.812.222.47--
Long-Term Deferred Tax Liabilities
3.783.87--1.42-
Total Liabilities
445.94521.04516.59440.92240.99232.89
Common Stock
374.13374.13375.93379.16372.51322.59
Additional Paid-In Capital
898.21898.21903.73912.8888.99630.63
Retained Earnings
59.5185.62324.3455.64444399.25
Treasury Stock
-6.77-6.77-14.33-27.92--
Total Common Equity
1,3251,3511,5901,7201,7051,352
Minority Interest
0.030.030.049.710-
Shareholders' Equity
1,3251,3511,5901,7291,7151,352
Total Liabilities & Equity
1,7711,8722,1062,1701,9561,585
Total Debt
239.46300.95254.34175.6939.6937.61
Net Cash (Debt)
-118.44-76.55-64.69193.51514.64205.94
Net Cash Growth
----62.40%149.90%-54.92%
Net Cash Per Share
-0.33-0.21-0.170.531.610.64
Filing Date Shares Outstanding
372.91374.13375.93379.16372.51322.59
Total Common Shares Outstanding
372.91374.13375.93379.16372.51322.59
Working Capital
-34.82-23.11-10.81184.96521.99358.67
Book Value Per Share
3.553.614.234.544.584.19
Tangible Book Value
1,0431,0681,1071,2001,219850.59
Tangible Book Value Per Share
2.802.852.953.163.272.64
Buildings
-374.7373.99372.77372.77371.38
Machinery
-583.28571.12528.14391.32364.87
Construction In Progress
-351.06335.22273.35207.598.13
Source: S&P Global Market Intelligence. Standard template. Financial Sources.